Senti Biosciences, Inc. - Common Stock, par value $0.0001 per share (SNTI)

Historical Holders from Q3 2024 to Q3 2025

Symbol
SNTI on Nasdaq
CUSIP
81726A209
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
29.8M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
5.61M
Holdings value
$7.91M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
15
Number of buys
9
Number of sells
-7
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Senti Biosciences, Inc. - Common Stock, par value $0.0001 per share (SNTI)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Celadon Partners SPV 24 45% +19.5% $20.8M $5.62M 13.4M +37.1% Celadon Partners SPV 24 Aug 29, 2025
New Enterprise Associates 15, L.P. 14.5% $12.2M 3.78M New Enterprise Associates 15, L.P. Mar 6, 2025
Nantahala Capital Management, LLC 8.12% -18.7% $7.19M $5.54M 2.22M +336% Nantahala Capital Management, LLC Mar 31, 2025
ARMISTICE CAPITAL, LLC 4.99% -50% $4.66M $2.93M 1.44M +169% Armistice Capital, LLC Mar 31, 2025
Nantahala Capital Partners Limited Partnership 1.9% -66.8% $1.63M $651K 503K +66.7% NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP Mar 31, 2025

Institutional Holders of Senti Biosciences, Inc. - Common Stock, par value $0.0001 per share (SNTI)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 5.61M $7.91M -$2.93M $1.41 15
2025 Q2 6.48M $13.7M +$1.72M $2.11 14
2025 Q1 5.66M $19M +$16.8M $3.36 14
2024 Q4 667K $2.34M -$330K $3.51 14
2024 Q3 764K $1.73M +$1.72M $2.26 12